Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Hypoxia-responsive core-cross-linked supramolecular nanoprodrug based on dendritic drug-drug conjugates for synergetic anticancer therapy

Fig. 6

(A) Schematic illustration experiment design for CSN-IR806/CB + L group. (B) Time-dependent HepG2 tumor growth curves. (C) TIR for different groups. (D) Body weight changes of mice on time. (E) Photographs of tumors at the end of treatment, and H&E, TUNEL, PCNA, and HIF-1α staining images of tumor tissues at the end of experiment. *P < 0.1, and ***P < 0.001

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us